---
document_datetime: 2023-09-21 18:19:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/elonva-epar-all-authorised-presentations_en.pdf
document_name: elonva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.828818
conversion_datetime: 2025-12-24 05:30:50.040483
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength       | Pharmaceutical Form    | Route of Administration   | Packaging                  | Content   | Package size                    |
|-----------------|-----------------|----------------|------------------------|---------------------------|----------------------------|-----------|---------------------------------|
| EU/1/09/609/001 | Elonva          | 100 micrograms | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 0.5 ml    | 1 pre-filled syringe + 1 needle |
| EU/1/09/609/002 | Elonva          | 150 micrograms | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 0.5 ml    | 1 pre-filled syringe + 1 needle |